Cargando…
Ondansetron ameliorates depression associated with obesity in high-fat diet fed experimental mice: An investigation-based on the behavioral, biochemical, and molecular approach
INTRODUCTION: Obesity is an important risk factor for depression as more than half of the obese population is susceptible for depression at double rate. Our earlier studies reported the antidepressant potential of 5-HT(3) receptor antagonist, ondansetron (OND) in depression associated obesity using...
Autores principales: | Kurhe, Yeshwant, Mahesh, Radhakrishnan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754936/ https://www.ncbi.nlm.nih.gov/pubmed/29326489 http://dx.doi.org/10.4103/ijp.IJP_805_16 |
Ejemplares similares
-
Pioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice
por: Kurhe, Yeshwant, et al.
Publicado: (2016) -
Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats
por: Gupta, Deepali, et al.
Publicado: (2013) -
Pharmacological evaluation of novel 5-HT(3) receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery
por: Gupta, Deepali, et al.
Publicado: (2015) -
Antidepressant-like effect of a novel 5-HT(3) receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests
por: Kurhe, Yeshwant, et al.
Publicado: (2014) -
Anti-anxiety effect of a novel 5-HT(3) receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice
por: Kurhe, Yeshwant Vijay, et al.
Publicado: (2014)